This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks With Upgrades: DVN, HTLD, LRCX, XEC, CFN

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cimarex Energy

The oil and gas exploration company reported Wednesday fourth-quarter earnings of $116.9 million, or $1.36 a share, slightly down from year-ago earnings of $117.6 million, or $1.37.

"We reiterate our Perform rating on the shares due to XEC's below-average production growth rate, estimated at 4-10% in 2012, and an oil/gas production mix that continues to be highly levered to gas. XEC does not have any gas hedges in 2012 or 2013, leaving it fully exposed to the current low gas price environment," Oppenheimer analysts wrote in a report Thursday.

Shares of Cimarex Energy were upgraded to buy from hold by TheStreet Ratings.

Cimarex has a forward P/E of 11.61; the average for exploration and production companies is 20.04. For comparison, Southwestern Energy (SWN) and Concho Resources (CXO) both have higher forward P/Es of 21.47 and 21.87, respectively.

Thirteen of the 21 analysts who cover Cimarex rated it a buy; eight rated it a hold.

Cimarex gets a B- grade from TheStreet Ratings with a $94.24 price target. The stock closed Thursday at $80.96 and has increased 30.79% year to date.


CareFusion

The medical technology company earlier this month reported second-quarter earnings of $95 million, or 42 cents a share, up from year-ago earnings of $76 million, or 34 cents.

"We estimate that in order to meet management's goal of 20%-plus operating margin exiting fiscal 2014, the company needs to reduce expenses by 3% from the fiscal 2011 base," Morgan Keegan analysts wrote in a report Friday. "Given the sheer number of cost reduction initiatives that are ongoing, we believe that management can meets its goals."

Shares of CareFusion were upgraded to buy from hold by TheStreet Ratings.

CareFusion has a forward P/E of 12.89; the average for medical equipment companies is 32.59. For comparison, Abiomed (ABMD) has a forward P/E of 121.79.

Of the 16 analysts who cover CareFusion, nine rated it a buy and seven rated it a hold.

TheStreet Ratings gives CareFusion a B grade with a $29.29 price target. The stock closed Thursday at $25.86 and has increased 1.77% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CFN $0.00 0.00%
DVN $56.68 0.00%
HTLD $19.93 0.00%
LRCX $81.14 0.00%
XEC $105.59 0.00%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs